Spitz tumours are defined in the 2018 WHO classification of skin tumours by the presence of specific genetic alterations, such as HRAS mutations or kinase fusions (BRAF, MAP3K8, ROS1, ALK, NTRK1, NTRK3, RET, MET and MERTK) [13]. This evidence concerns the gene ROS1 and skin neoplasm.